C. Jeffrey Dekker

C. Jeffrey Dekker

Former Chief Financial OfficeratOruka Therapeutics· In proxies 2023–2024

Pay in FY2024+134% from the year before · Oruka Therapeutics stock +76.8% the same year

C. Jeffrey Dekker was paid $756.6K in FY2024 (Dec), up 134%. Oruka Therapeutics stock rose 76.8% that year.

Pay$100 in the stock at the end of FY22 → $127
Pay is from the Summary Compensation Table of each Oruka Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Oruka TherapeuticsPublic company · 3 yr
    • Former Chief Financial Officer2023 – Present · 3 yrStock in role +549%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?